1 Min Read
April 12 (Reuters) - ADYNXX:
* ADYNXX - PHASE 2 STUDY RESULTS OF BRIVOLIGIDE (AYX1) FOR TREATMENT OF POST SURGICAL PAIN DID NOT MEET PRIMARY ENDPOINT Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.